Elbasvir; Grazoprevir Tablet — FDA Drug Shortage

To Be Discontinued — Merck Sharp & Dohme LLC

The FDA lists a drug shortage record for Elbasvir; Grazoprevir Tablet (tablet) from Merck Sharp & Dohme LLC with status To Be Discontinued. The shortage was first posted on 10/17/2025.

Shortage Details

Status
To Be Discontinued
Company
Merck Sharp & Dohme LLC
Package NDC
0006-3074-02
Dosage Form
Tablet
Presentation
Zepatier, Tablet, 50 mg; 100 mg (NDC 0006-3074-02)
Initial Posting
10/17/2025
Revised Date